We established cohorts of all genotypes with littermate controls and monitored these for over 500 days (∼18 months) to determine if overexpression of ADAR1 or any of the specific isoforms impacted hematopoiesis or was sufficient to initiate cancer (Figure 4A). Here, ADAR is linked to cancer.